Newstral
Article
South China Morning Post on 2022-09-30 07:41
China’s first mRNA Covid-19 vaccine approved for use in Indonesia
Related news
- Covid-19: China’s Sinopharm mRNA vaccine approved for clinical trialsSouth China Morning Post
- China Gets Its First mRNA Vaccine Approval — in IndonesiaThe New York Times
- China approved an mRNA Covid vaccine, its first.The New York Times
- BioNTech MRNA Vaccine Approved In Hong Kong, Week In ReviewForbes
- Domestic clinical trials planned for China’s mRNA Covid-19 vaccineSouth China Morning Post
- FChina’s Sinopharm seeks to develop its own mRNA Covid vaccineft.com
- China’s first mRNA vaccine ready for final stage trials overseasSouth China Morning Post
- How China’s Sinovac compares with BioNTech’s mRNA vaccineThe Economist
- BChina’s Biggest Covid Failure Is Not Deploying an mRNA Vaccinebloomberg.com
- FNew Covid variants threaten China’s mRNA vaccine hopesft.com
- Chinese vaccine approved for military useNZ Herald
- Coronavirus: Indonesia, Mexico approve late-stage trials of Chinese mRNA vaccine hopefulSouth China Morning Post
- China’s first coronavirus vaccine approved for clinical trialsNew York Post
- Can China’s home-grown mRNA Covid-19 vaccine pass its final tests?South China Morning Post
- China’s insistence on a homegrown mRNA vaccine haunts its COVID-control effortsLA Times
- Indonesia green-lights emergency use of Chinese vaccineSeattle Times
- Indonesia resumes use of AstraZeneca’s COVID-19 vaccineSeattle Times
- Coronavirus: Turkey approves China’s Sinovac vaccine for emergency useSouth China Morning Post
- BCoronavirus: Putin says vaccine has been approved for usebbc.co.uk
- Covid Pfizer vaccine approved for use next weekBBC